Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges.

ABSTRACT: Chronic hand eczema (CHE) is a common and burdensome inflammatory skin condition seen in up to 10% of the population, more often in high-risk occupational workers. Topical therapeutics comprise the standard of care, but up to 65% of cases do not resolve after treatment, and moderate-to-severe cases are often resistant to topical therapeutics and require systemic options instead. To date, there are no systemic therapeutics approved to treat CHE in the United States, but several drugs are under investigation as potential treatments for CHE. The primary focus of this review is on the novel therapeutics, topical and systemic, that are under investigation in recently completed or currently ongoing trials. This review also briefly outlines the existing treatments utilized for CHE, often with lim

SUBMITTER: Dubin C 

PROVIDER: S-EPMC7780849 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature